# Burroughs Wellcome Co.

- Location (FDA's records): Mchenry, IL
- FDA decisions: 17 (1977–1982): 17 510(k) clearances
- Product codes: GTZ (2), JHI (2), DON (2), DDC (2), KTS (1), CDP (1), CDX (1), GTJ (1), JLW (1), DCN (1), KHQ (1), DAC (1)
- Predicates its devices cite: 0 (0 its own); citations of its devices by later devices: 0 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Recent decisions
- K820069: Wellcogen Group B (Feb 18, 1982)
- K813508: Sac-Cel (Dec 29, 1981)
- K810215: Dac-Cel HCG (Apr 17, 1981)
- K810214: Dac-Cel Diagnatal (Mar 6, 1981)
- K810213: Dac-Cel TSH (Feb 10, 1981)
- K810212: Dac-Cel T3 Uptake (Feb 10, 1981)
- K791232: Dac-Cel T3 (Sep 4, 1979)
- K791231: Dac-Cel T4 (Sep 4, 1979)

Source page: https://510kreport.com/company/burroughs-wellcome